coronary artery disease
The AI co-developed with ASX-listed Artrya can outperform the Agatston score in predicting cardiac events.
The model could be deployed as a decision support tool in emergency departments.
A Singaporean startup leverages Asian-specific databases in making heart disease risk assessments.
It has comparable safety outcomes to coronary artery intervention guided by expensive 3D imaging.
Also, Global Health is deploying its patient engagement and data solutions to the upcoming George Centre.
The AI solution automatically analyses cardiac CT scans and produces reports within 15 minutes.